Record Details


Field	Value

Title	Replication Data for: The Reputational Dividends of Collaborating with a Highly Reputable Agency: The Case of the FDA and Its Domestic Partner Agencies

Identifier	https://doi.org/10.7910/DVN/GX6AEU

Creator	Maor, Moshe Sulitzeanu-Kenan, Raanan Balmas, Meital

Publisher	Harvard Dataverse

Description	Utilizing a dataset covering 30 U.S. federal agencies over a period of 34 years (1980–2013), we estimate the short and long-term reputational effects of interagency collaboration. Collaboration is measured by the number of memorandums of understanding (MOUs) in effect between each agency and the FDA, while agency reputation is assessed using an automated measure of media-coverage valence (positive/negative tone) for each agency-year. To account for potential reverse and reciprocal causality, we utilize cross-lagged fixed-effects models. We find evidence of moderate rises in reputation due to increased collaboration with the FDA. These effects persist significantly for two years, before decaying to null after four years. Employing similar analyses, we furthermore estimate reversed causality – of reputation on the level of consequent collaboration – finding no evidence of such effects.

Subject	Social Sciences reputaion interagency collaboration FDA

Contributor	Sulitzeanu-Kenan, Raanan

ICAR Research Data Repository for Knowledge Management